Cardiovascular Morbidity and Mortality and Renal Artery Stenosis

Progress in Cardiovascular Diseases

Volumn 52, Issue 3, 2009, Pages 238-242

  Colyer Jr , William R ^a   Cooper, Christopher J ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Mortality; Outcomes; Renal artery stenosis; Treatment

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG TARGETING; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY FAILURE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVASCULARIZATION; RISK FACTOR; STENT;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; HUMANS; RENAL ARTERY OBSTRUCTION; RENIN-ANGIOTENSIN SYSTEM;

EID: 71549137741     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2009.09.004     Document Type: Article

References (54)

1. Conlon P.J., Athirakul K., Kovalik E., et al. Survival in renal vascular disease. J Am Soc Nephrol 9 (1998) 252-256
2. Rossi G.P., Rossi A., Zanin L., et al. Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertens 5 (1992) 8-15
3. Louie J., Isaacson J.A., Zierler R.E., et al. Prevalence of carotid and lower extremity arterial disease in patients with renal artery stenosis. Am J Hypertens 7 (1994) 436-439
4. Valentine R.J., Myers S.I., Miller G.L., et al. Detection of unsuspected renal artery stenoses in patients with abdominal aortic aneurysms: refined indications for preoperative aortography. Ann Vasc Surg 7 (1993) 220-224
5. Zierler R.E., Bergelin R.O., Polissar N.L., et al. Carotid and lower extremity disease in patients with renal artery atherosclerosis. Arch Intern Med 158 (1998) 761-767
6. Miralles M., Corominas A., Cotillas J., et al. Screening for carotid and renal artery stenoses in patients with aortoiliac disease. Ann Vasc Surg 12 (1998) 17-21
7. Kuroda S., Nishida N., Uzu T., et al. Prevalence of renal artery stenosis in autopsy patients with stroke. Stroke 31 (2000) 61-65
8. Uzu T., Inoue T., Fuji T., et al. Prevalence and predictors of renal artery stenosis in patients with myocardial infarction. Am J Kidney Dis 29 (1997) 733-738
9. Crowley J.J., Santos R.M., Peter R.H., et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 136 (1998) 913-918
10. Jean W.J., Al-Bittar I., Zwicke D.L., et al. High incidence of renal artery stenosis in patients with coronary artery disease. Catheter Cardiovasc Diagn 32 (1994) 8-10
11. Valentine R.J., Martin J.D., Myers S.I., et al. Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses. J Vasc Surg 14 (1991) 195-199
12. Choudhri A.H., Cleland J.G.F., Rowlands P.C., et al. Unsuspected renal artery stenosis in peripheral vascular disease. Br Med J 301 (1990) 1197-1198
13. Olin J.W., Melia M., Young J.R., et al. Prevalence of renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 88 (1990) 46N-51N
14. Holley K.E., Hunt J.C., Brown A.L., et al. Renal artery stenosis. A clinical-pathologic study in normotensive and hypertensive patients. Am J Med 37 (1964) 14-22
15. Eyler W.R., Clarck M.D., Garman J.E., et al. Angiography of the renal arteries including a comparative study of renal artery stenoses in patients with and without hypertension. Radiology 78 (1962) 879-892
16. Swartbol P., Thorvinger B.O., Parson H., et al. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol 11 (1992) 195-199
17. Sawicki P.T., Kaiser S., Heinemann L., et al. Prevalence of renal artery stenosis in diabetes mellitus-an autopsy study. J Intern Med 229 (1991) 489-492
18. Wollenweber J., Sheps S.G., and Davis G.D. Clinical course of atherosclerotic renovascular disease. Am J Cardiol 21 (1968) 60-71
19. Sheps S.G., Osmundson P.J., Hunt J.C., et al. Hypertension and renal artery stenosis: serial observations on 54 patients treated medically. Clin Pharm Ther 6 (1965) 700-709
20. Isles C., Main J., O'Connell J., et al. Survival associated with renovascular disease in Glasgow and Newcastle: a collaborative study. Scot Med J 35 (1990) 70-73
21. Wright J.R., Shurrab A.E., Cheung C., et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renal vascular disease. Am J Kidney Dis 39 (2002) 1153-1161
22. Kalra P.A., Guo H., Kausz A.T., et al. Atherosclerotic renal vascular disease in United State patients aged 67 years and older: risk factors, revascularization, and prognosis. Kidney Int 68 (2005) 293-301
23. Baboolal K., Evans C., and Moore R.H. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renal vascular disease. Am J Kidney Dis 31 (1998) 971-977
24. Dorros G., Jaff M., Mathiak L., et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four year follow up of 1,058 successful patients. Catheter Cardiovasc Interv 55 (2002) 182-188
25. Bates M.C., Campbell J.C., Stone P.A., et al. Factors affecting long-term survival following renal artery stenting. Catheter Cardiovasc Interv 69 (2007) 1037-1043
26. Kennedy D.J., Colyer W.R., Brewster P.S., et al. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis 42 (2003) 926-935
27. Bax L., Woittiez A.J.J., Kouwenberg H.J., et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function. A randomized trial. Ann Intern Med 150 (2009) 840-848
28. Shlipak M.G., Heidenreich P.A., Noguchi H., et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 137 (2002) 555-562
29. Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infraction and renal dysfunction: a high risk combination. Ann Intern Med 137 (2002) 563-570
30. Mann J.F.E., Gerstein H.C., Dulau-Florea I., et al. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int 84 (2003) S192-S196
31. Wheeler D.C., Townend J.N., and Landray M.J. Cardiovascular risk factors in predialysis patients: baseline data from the chronic renal impairment in Birmingham (CRIB) study. Kidney Int 84 (2003) S201-S203
32. Holland D.C., and Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant 15 (2000) 650-658
33. Goldblatt H., Lynch J., Hanzal R.F., et al. Studies on experimental hypertension: production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 59 (1934) 347-379
34. Montecucco F., Pende A., and Mach F. The rennin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. Mediators Inflamm 2009 (2009) 752406 Epub 2009 Apr 14
35. Akers W.S., Cross A., Speth R., et al. Renin-angiotensin system and sympathetic nervous system in cardiac pressure overload hypertrophy. Am J Physiol Circ Physiol 279 (2000) H2797-H2806
36. Schmidt-Ott K.M., Kagiyama S., and Phillips. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 93 (2000) 65-77
37. Keidar S., Kaplan M., Hoffman A., et al. Angiotensin II stimulates macrophage-mediated oxidation of low-density lipoprotein. Atherosclerosis 115 (1995) 201-215
38. Morawietz H., Rueckschloss U., Niemann B., et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 100 (1999) 899-902
39. Harden P.N., MacLeod M.J., Rodger R.S.C., et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349 (1997) 1133-1136
40. Watson P.S., Hadjipetrou P., Cox S.V., et al. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renal vascular disease. Circulation 102 (2000) 1671-1677
41. Leertouwer T.C., Derkx F.H., Pattynama P.M., et al. Functional effects of renal artery stent placement on treated and contralateral kidneys. Kidney Int 62 (2002) 574-579
42. van Jaarsveld BC, Krijnen P, Pieterman, et al: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 342:1007-1014.
43. Plouin P.F., Chatellier G., Darne B., et al. Blood pressure outcome in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs. Angioplastie (EMMA) Study Group. Hypertension 31 (1998) 823-829
44. Webster J., Marshall F., Abdalla M., et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 12 (1998) 329-355
45. Schwarzwalder U., and Zeller T. Critical review of indications for renal artery stenting: do randomized trials give the answer?. Catheter Cardiovasc Intervent (2009) Published Online 7 April
46. Levin A., Linas S., Luft F.C., et al. Controversies in renal artery stenosis: a review by the American society of nephrology advisory group on hypertension. Am J Nephrol 27 (2007) 212-220
47. The Heart Outcomes Prevention Evaluation study investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 342 (2000) 145-153
48. The ON TARGET investigators. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 358 (2008) 1547-1559
49. Onuigbo M.A., and Onuigbo N.T. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63- month experience. Ren Fail 30 (2008) 363-371
50. Onuigbo M.A.C., and Onuigbo N.T.C. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis. Q J Med 101 (2008) 519-527
51. Losito A., Errico R., Santirosi P., et al. Long term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol Dial Transplant 20 (2005) 1604-1609
52. Hackam D.G., Duong-HUA M.L.D., Mamdani M., et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am Heart J 156 (2008) 549-555
53. Cooper C.J., Murphy T.P., Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 152 (2006) 59-66
54. Silva V.S., Martin L.C., Franco R.J., et al. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am J Hypertens 21 (2008) 1163-1168